Cargando…
Intra-tumoral heterogeneity and immune responses predicts prognosis of gastric cancer
Chemotherapy resistance eventually develops in patients with gastric cancer (GC). Intra-tumoral heterogeneity (ITH) refers to the intercellular genetic variations and phenotypic diversity that affect responses to drug therapy. We measured ITH using mutant-allele tumor heterogeneity (MATH) derived fr...
Autores principales: | Feng, Wanjing, Wang, Yue, Chen, Siyuan, Zhu, Xiaodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762511/ https://www.ncbi.nlm.nih.gov/pubmed/33259333 http://dx.doi.org/10.18632/aging.202238 |
Ejemplares similares
-
Severe loss of visceral fat and skeletal muscle after chemotherapy predicts poor prognosis in metastatic gastric cancer patients without gastrectomy
por: Feng, Wanjing, et al.
Publicado: (2020) -
Identification of a Four-Gene-Based SERM Signature for Prognostic and Drug Sensitivity Prediction in Gastric Cancer
por: Jia, Xiya, et al.
Publicado: (2022) -
Intra-tumoral angiogenesis correlates with immune features and prognosis in glioma
por: Zhang, Qing, et al.
Publicado: (2022) -
Development and validation of an intra-tumor heterogeneity-related signature to predict prognosis of bladder cancer: a study based on single-cell RNA-seq
por: Zhou, Ranran, et al.
Publicado: (2021) -
Simulating the Dynamic Intra-Tumor Heterogeneity and Therapeutic Responses
por: Liu, Yongjing, et al.
Publicado: (2022)